AstraZeneca’s BioPharmaceuticals Business Unit (BBU) is at the forefront of transforming patient outcomes across key therapy areas, including Cardiovascular, Renal & Metabolism (CVRM) and Respiratory & Immunology (R&I). Driven by science and innovation, we work to deliver life-changing medicines tha......